Sanjeevani Arora

Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients

Ilya G. Serebriiskii, Caitlin Connelly, Garrett M. Frampton et al. · Nature Communications · 2019 · 213 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Downregulation of XPF–ERCC1 enhances cisplatin efficacy in cancer cells☆

Sanjeevani Arora, Anbarasi Kothandapani, Kristin Tillison et al. · DNA repair · 2010 · 181 citations

Medicine, Molecular Genetics, Oncology +9

Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells

Sanjeevani Arora, Joshua Heyza, Hao Zhang et al. · Oncotarget · 2016 · 57 citations · Full text

Medicine, Medicinal Chemistry, Oncology +11

Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells

Joshua Heyza, Sanjeevani Arora, Hao Zhang et al. · Nutrients · 2018 · 50 citations · Full text

Medicine, Oncology, Pharmacology +13

Reversible cell cycle inhibition and premature aging features imposed by conditional expression of p16^Ink4a

Amelie Boquoi, Sanjeevani Arora, Tina Chen et al. · Aging Cell · 2014 · 47 citations · Full text

Education, Cell Biology, Molecular Genetics +17